StoryFunding
Axoft raises $55M Series A to expand clinical trials and build manufacturing facility
Axoft closed an oversubscribed $55M Series A round led by C.P. Group Innovation with participation from Alumni Ventures, Stanford President's Venture Fund, Hillhouse Investment and Gaorong Ventures. The funding brings total to over $60M and will support global clinical trial expansion, FDA regulatory approval, construction of a GMP manufacturing facility, and team growth in software, microfabrication and chemistry.